查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654223

光化性角化症治疗市场规模、份额、趋势分析报告，分类：治疗方法、药物类别、最终用途、地区、细分预测，2025-2030 年

Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class (NSAIDs), By End use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

光化性角化症治疗市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球光化性角化症治疗市场规模预计到2030年将达到89.3亿美元，2025年至2030年复合年增长率为4.1%。

由于用于治疗光化性角化病的药物广泛可用、人们对该疾病的认识不断提高以及 AK 治疗的数量不断增加等因素，预计市场将迎来增长机会。此外，预计预测期内光化性角化病患病率的增加和全球老年人口的增加将推动市场成长。

侵袭性鳞状细胞癌可由 AK 的恶性转化 (iSCC) 发展而来。 iSCC 有几种潜在病因，但 AK 是最常见的原因之一。此外，基底细胞癌和非黑色素瘤皮肤癌也可能由 AK 引起。因此，无论销售管道如何，对 AK 产品的需求都是由对光化性角化病的早期诊断和治疗作为预防併发症的策略所推动的。

此外，未来药物和联合治疗的兴起也在推动市场的发展。例如，Almirall, SA 的 Klisyri（扩大适应症）处于 III 期研发阶段。此外，创新药物的接受度和商业化的提高也有望推动市场成长。此外，研发活动的活性化预计将加速治疗光化性角化症的新药的核准，从而推动预测期内的成长。

主要企业正在采取产品发布、合作伙伴关係和扩大策略等策略性倡议，以增加市场占有率。例如，2022 年 6 月，BIOFRONTERA AG 宣布瑞士的 Louis Widmer SA 已获得 Ameluz 用于治疗身体躯干、四肢和颈部光化性角化病的营销核准延长。此外，2020 年 7 月，BIOFRONTERA AG 宣布与 Galenica AB 签署协议，在挪威、芬兰、挪威和冰岛分销 BF-RhodoLED 和 Ameluz。

光化性角化症治疗市场报告重点：

  • 由于冷冻疗法手术在治疗光化性角化症的应用越来越多，预计到 2024 年手术将占据最大的收入份额，达到 63.8%。
  • 核苷代谢抑制剂在 2024 年占据了最大的收益占有率，预计在预测期内仍将保持主导地位。
  • 预计亚太地区将以最快的速度成长，预测期内复合年增长率为 5.4%，这归因于 AK 患病率高、医疗保健基础设施快速发展以及亚太国家医疗保健支出不断增加等因素。
  • 由于人们对光化性角化病的认知不断提高、强大治疗方案的可用性以及医疗保健基础设施的不断改善，北美在 2024 年占据了市场主导地位，收入份额最大，为 40.5%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 光化性角化症治疗市场变数、趋势与范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第 4 章 光化性角化症治疗市场：治疗方法业务分析

  • 2024 年和 2030 年治疗方法市场占有率
  • 治疗方法细分仪表板
  • 2018 年至 2030 年按治疗方法的市场规模、预测与趋势分析
  • 局部的
  • 外科手术
  • 动态疗法

第五章 光化性角化症治疗市场-药物类别业务分析

  • 2024 年及 2030 年药物类别市场占有率
  • 药品类别细分仪表板
  • 2018 年至 2030 年按药物类别分類的市场规模、预测和趋势分析
  • 核苷代谢抑制剂
  • NSAIDs
  • 免疫反应调节剂
  • 光增强剂
  • 其他的

6. 光化性角化症治疗市场-最终用途业务分析

  • 2024 年及 2030 年终端用途市场占有率
  • 最终用途细分仪表板
  • 2018 年至 2030 年按最终用途分類的市场规模、预测和趋势分析
  • 医院
  • 私人诊所
  • 居家护理
  • 其他的

第七章 光化性角化症治疗市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018 年至 2030 年市场规模及预测趋势分析：
  • 北美洲
    • 按国家
    • 美国
    • 加拿大
  • 欧洲
    • 按国家
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 按国家
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 按国家
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国

第八章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Almirall, SA
    • LEO Pharma A/S
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Galderma
    • Ortho Dermatologics（Bausch Health Companies Inc.）
    • BIOFRONTERA Inc
    • Hill Dermaceuticals, Inc
    • 3M
    • Alma Lasers
Product Code: GVR-2-68038-940-1

Actinic Keratosis Treatment Market Growth & Trends:

The global actinic keratosis treatment market size is expected to reach USD 8.93 billion by 2030, registering a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness growth opportunities owing to factors such as the wide availability of actinic keratosis therapeutics, rising awareness about the disease, and the rise in AK treatment. Moreover, the increasing prevalence of actinic keratosis and the rising geriatric population across the globe are expected to fuel the market growth during the forecast period.

Invasive squamous cell carcinoma may develop from AK when it becomes malignant (iSCC). Despite the fact that there are a number of potential causes for iSCC, AK is one of the most frequent ones. Additionally, basal cell carcinoma and non-melanoma skin cancer could result from AK. As a result, the demand for AK products across sales channels is being driven by the early diagnosis and treatment of actinic keratosis as a preventive strategy for comorbidities.

In addition, future pipeline medications and the increased use of combination therapy are key market drivers. For instance, Almirall, S.A. has Klisyri (extended label) in phase III of R&D. Furthermore, a rise in the acceptance and commercialization of innovative drugs is another factor that is predicted to fuel market growth. Moreover, increased R&D activities are expected to accelerate the approval of novel drugs used in the treatment of actinic keratosis, hence, propelling the growth over the forecast period.

Key players are adopting strategic initiatives such as product launches, partnerships, and expansion strategies to increase their market share across the globe. For instance, in June 2022, BIOFRONTERA AG announced that its license and marketing authorization holder Louis Widmer SA based in Switzerland has received an extension of its marketing authorization for the management of actinic keratosis in the trunk, extremities, and neck with Ameluz. Moreover, in July 2020, BIOFRONTERA AG announced that it has signed an agreement with Galenica AB for the marketing of BF-RhodoLED and Ameluz in Norway, Finland, and Iceland.

Actinic Keratosis Treatment Market Report Highlights:

  • Surgery held the largest revenue share of 63.8% in 2024 owing to the rising adoption of cryotherapy surgery in the management of actinic keratosis
  • Nucleoside metabolic inhibitors held the largest revenue share in 2024 and is expected to retain its dominance over the forecast period
  • Asia Pacific is expected to grow at the fastest CAGR of 5.4% during the forecast period due to factors such as the high prevalence of AK, rapidly evolving healthcare infrastructure, and rising healthcare expenditures by Asia Pacific countries
  • North America dominated the market with the largest revenue share of 40.5% in 2024 due to the rising awareness among people about actinic keratosis, availability of robust treatment options, and improvements in healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapy
    • 1.2.2. Drug Class
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Actinic Keratosis Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Actinic Keratosis Treatment Market: Therapy Business Analysis

  • 4.1. Therapy Market Share, 2024 & 2030
  • 4.2. Therapy Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
  • 4.4. Topical
    • 4.4.1. Topical Market, 2018 - 2030 (USD Million)
  • 4.5. Surgery
    • 4.5.1. Surgery Market, 2018 - 2030 (USD Million)
  • 4.6. Photodynamic Therapy
    • 4.6.1. Photodynamic Therapy Market, 2018 - 2030 (USD Million)

Chapter 5. Actinic Keratosis Treatment Market: Drug Class Business Analysis

  • 5.1. Drug Class Market Share, 2024 & 2030
  • 5.2. Drug Class Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 5.4. Nucleoside Metabolic Inhibitor
    • 5.4.1. Nucleoside Metabolic Inhibitor Market, 2018 - 2030 (USD Million)
  • 5.5. NSAIDs
    • 5.5.1. NSAIDs Market, 2018 - 2030 (USD Million)
  • 5.6. Immune Response Modifiers
    • 5.6.1. Immune Response Modifiers Market, 2018 - 2030 (USD Million)
  • 5.7. Photoenhancers
    • 5.7.1. Photoenhancers Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Actinic Keratosis Treatment Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.5. Private Clinics
    • 6.5.1. Private Clinics Market, 2018 - 2030 (USD Million)
  • 6.6. Homecare
    • 6.6.1. Homecare Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Actinic Keratosis Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Actinic Keratosis Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Actinic Keratosis Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Actinic Keratosis Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Mexico Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Framework
      • 7.7.4.3. Competitive Insights
      • 7.7.4.4. Argentina Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Actinic Keratosis Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Almirall, S.A
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. LEO Pharma A/S
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Sun Pharmaceutical Industries Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Novartis AG
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Galderma
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Ortho Dermatologics (Bausch Health Companies Inc.)
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. BIOFRONTERA Inc
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Hill Dermaceuticals, Inc
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. 3M
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Alma Lasers
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 5 Global actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 6 Global actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 9 North America actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 10 North America actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 12 U.S. actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 13 U.S. actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 15 Canada actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 16 Canada actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Europe actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 19 Europe actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 20 Europe actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 21 UK actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 22 UK actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 23 UK actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 25 Germany actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 26 Germany actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 27 France actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 28 France actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 29 France actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Italy actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 31 Italy actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 32 Italy actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Spain actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 34 Spain actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 35 Spain actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Japan actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 41 Japan actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 42 Japan actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 43 China actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 44 China actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 45 China actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 46 India actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 47 India actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 48 India actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 49 South Korea actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 50 South Korea actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 51 South Korea actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Australia actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 53 Australia actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 54 Australia actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Latin America actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 56 Latin America actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 57 Latin America actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 58 Latin America actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Brazil actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 60 Brazil actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 61 Brazil actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Mexico actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 63 Mexico actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 64 Mexico actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Argentina actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 66 Argentina actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 67 Argentina actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Middle East & Africa actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 69 Middle East & Africa actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 70 Middle East & Africa actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 72 South Africa actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 73 South Africa actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 74 South Africa actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 78 UAE actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 79 UAE actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 80 UAE actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Actinic keratosis treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapy outlook (USD Million)
  • Fig. 10 Drug class outlook (USD Million)
  • Fig. 11 End use outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 Actinic keratosis treatment market dynamics
  • Fig. 14 Actinic keratosis treatment market: Porter's five forces analysis
  • Fig. 15 Actinic keratosis treatment market: PESTLE analysis
  • Fig. 16 Actinic keratosis treatment market: Therapy segment dashboard
  • Fig. 17 Actinic keratosis treatment market: Therapy market share analysis, 2024 & 2030
  • Fig. 18 Topical market, 2018 - 2030 (USD Million)
  • Fig. 19 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 20 Photodynamic therapy market, 2018 - 2030 (USD Million)
  • Fig. 21 Actinic keratosis treatment market: Drug class segment dashboard
  • Fig. 22 Actinic keratosis treatment market: Drug class market share analysis, 2024 & 2030
  • Fig. 23 Nucleoside metabolic inhibitor market, 2018 - 2030 (USD Million)
  • Fig. 24 NSAIDs market, 2018 - 2030 (USD Million)
  • Fig. 25 Immune response modifiers market, 2018 - 2030 (USD Million)
  • Fig. 26 Photoenhancers market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Actinic keratosis treatment market: End use segment dashboard
  • Fig. 29 Actinic keratosis treatment market: End use market share analysis, 2024 & 2030
  • Fig. 30 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 31 Private clinics market, 2018 - 2030 (USD Million)
  • Fig. 32 Homecare market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2018 - 2030 (USD Million)
  • Fig. 34 Actinic keratosis treatment market revenue, by region
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 North America actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. country dynamics
  • Fig. 38 U.S. actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada country dynamics
  • Fig. 40 Canada actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 France country dynamics
  • Fig. 47 France actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea country dynamics
  • Fig. 60 South Korea actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia country dynamics
  • Fig. 62 Australia actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil country dynamics
  • Fig. 65 Brazil actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico country dynamics
  • Fig. 67 Mexico actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 MEA actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 Company categorization
  • Fig. 78 Company market position analysis
  • Fig. 79 Strategic framework